RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş.

Notice of Dividend Amount • May 5, 2025

Summary Info	Yönetim Kurulu'nun Kar Payı Dağıtılmamasına İlişkin Teklifi
Update Notification Flag	No
Correction Notification Flag	No
Postponed Notification Flag	No

Decision Date	05.05.2025
Type of Cash Dividend Payment	Cash Dividend Will Not Be Paid
Stock Dividend	Will Not Be Paid

Cash Dividend Payment Amount and Rates

Share Group Info	Payment	Cash Dividend To Be Paid For Share With Par Value of 1 TL - Gross (TL)	Cash Dividend To Be Paid For Share With Par Value of 1 TL - Gross (%)	Withholding Rate (%)	Cash Dividend To Be Paid For Share With Par Value of 1 TL - Net (TL)	Cash Dividend To Be Paid For Share With Par Value of 1 TL - Net (%)
A Grubu, İşlem Görmüyor, TRERTAL00026		0,0000000	0	0	0,0000000	0
B Grubu, RTALB, TRERTAL00018		0,0000000	0	0	0,0000000	0

Amount and Rate of Cash Dividend Stock Dividend Payment

Share Group Info	Amount of Stock Dividend (TL)	Rate of Stock Dividend (%)
A Grubu, İşlem Görmüyor, TRERTAL00026	0	0
B Grubu, RTALB, TRERTAL00018	0	0

Additional Explanations

Şirketimiz tarafından Sermaye Piyasası Kurulu'nun Seri II, 14.1 sayılı Tebliği hükümleri çerçevesinde Türkiye Finansal Raporlama Standartlarına uyumlu olarak hazırlanan ve PKF Aday Bağımsız Denetim AŞ tarafından denetlenen 01.01.2024 - 31.12.2024 hesap dönemine ait finansal tablolarda bağışlar eklenmiş net dağıtılabilir dönem karı 52.241.764,34 TL olmasına karşılık, yasal kayıtlarda net dağıtılabilir dönem karı bulunmaması nedeniyle, 2024 yılına dair kar payı dağıtılmamasına ilişkin teklifte bulunulmasına oy birliği ile karar verilmiştir.

DIVIDEND DISTRIBUTION TABLE

RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş. 01.01.2024/31.12.2024 Period Dividend Payment Table (TL)

1.Paid-In / Issued Capital	500.000.000
2. Total Legal Reserves (According to Legal Records)	35.141.800,2
Information on privileges in dividend distribution, if any, in the Articles of Association:	Kar Dağıtımında İmtiyaz Yoktur.

*	Based on CMB Regulations	Based on Legal Records
3. Current Period Profit	-51.662.864	-20.379.108,58
4. Taxes Payable (-)	-103.897.602	0
5. Net Current Period Profit	52.234.738	0
6. Losses in Previous Years (-)	0	0
7. Primary Legal Reserve (-)	0	0
8. Net Distributable Current Period Profit	52.234.738	0
Dividend Advance Distributed (-)
Dividend Advance Less Net Distributable Current Period Profit
9. Donations Made During The Year ( + )	7.026,34
10. Donation-Added Net Distributable Current Period Profit on which First Dividend Is Calculated	52.241.764,34
11. First Dividend to Shareholders
* Cash
* Stock
12. Dividend Distributed to Owners of Privileged Shares
13. Other Dividend Distributed
* To the Employees
* To the Members of the Board of Directors
* To Non-Shareholders
14. Dividend to Owners of Redeemed Shares
15. Second Dividend to Shareholders
16. Secondary Legal Reserves
17. Statutory Reserves
18. Special Reserves
19. Extraordinary Reserves	52.234.738
20. Other Distributable Resources